151 related articles for article (PubMed ID: 29945308)
1. Aberrant Expression of miR-142-3p and its Target Gene HMGA1 and FZD7 in Breast Cancer and its Clinical Significance.
Jia XP; Meng LL; Fang JC; Wang HW; Chen J; Zhou J; Wang CN; Jiang WF
Clin Lab; 2018 Jun; 64(6):915-921. PubMed ID: 29945308
[TBL] [Abstract][Full Text] [Related]
2. Antitumor effect of miR-27b-3p on lung cancer cells via targeting Fzd7.
Sun Y; Xu T; Cao YW; Ding XQ
Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4113-4123. PubMed ID: 29028088
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-142-3p inhibits cell proliferation and invasion of cervical cancer cells by targeting FZD7.
Deng B; Zhang Y; Zhang S; Wen F; Miao Y; Guo K
Tumour Biol; 2015 Sep; 36(10):8065-73. PubMed ID: 25976503
[TBL] [Abstract][Full Text] [Related]
4. miR-144-3p serves as a tumor suppressor by targeting FZD7 and predicts the prognosis of human glioblastoma.
Cheng ZX; Song YX; Wang ZY; Wang Y; Dong Y
Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4079-4086. PubMed ID: 29028093
[TBL] [Abstract][Full Text] [Related]
5. MiR-142-3p functions as a potential tumor suppressor in human osteosarcoma by targeting HMGA1.
Xu G; Wang J; Jia Y; Shen F; Han W; Kang Y
Cell Physiol Biochem; 2014; 33(5):1329-39. PubMed ID: 24803022
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-542-3p inhibits the growth of hepatocellular carcinoma cells by targeting FZD7/Wnt signaling pathway.
Wu W; Dang S; Feng Q; Liang J; Wang Y; Fan N
Biochem Biophys Res Commun; 2017 Jan; 482(1):100-105. PubMed ID: 27815069
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-372-3p promotes the epithelial-mesenchymal transition in breast carcinoma by activating the Wnt pathway.
Fan X; Huang X; Li Z; Ma X
J BUON; 2018; 23(5):1309-1315. PubMed ID: 30570852
[TBL] [Abstract][Full Text] [Related]
8. miR-625 suppresses cell proliferation and migration by targeting HMGA1 in breast cancer.
Zhou WB; Zhong CN; Luo XP; Zhang YY; Zhang GY; Zhou DX; Liu LP
Biochem Biophys Res Commun; 2016 Feb; 470(4):838-44. PubMed ID: 26806308
[TBL] [Abstract][Full Text] [Related]
9. Aberrant expression of a five-microRNA signature in breast carcinoma as a promising biomarker for diagnosis.
Bitaraf A; Babashah S; Garshasbi M
J Clin Lab Anal; 2020 Feb; 34(2):e23063. PubMed ID: 31595567
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-504 functions as a tumor suppressor in hepatocellular carcinoma through inhibiting Frizzled-7-mediated-Wnt/β-catenin signaling.
Quan H; Li B; Yang J
Biomed Pharmacother; 2018 Nov; 107():754-762. PubMed ID: 30142536
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-137, an HMGA1 target, suppresses colorectal cancer cell invasion and metastasis in mice by directly targeting FMNL2.
Liang L; Li X; Zhang X; Lv Z; He G; Zhao W; Ren X; Li Y; Bian X; Liao W; Liu W; Yang G; Ding Y
Gastroenterology; 2013 Mar; 144(3):624-635.e4. PubMed ID: 23201162
[TBL] [Abstract][Full Text] [Related]
12. MiR-1-3p enhances the sensitivity of ovarian cancer cells to ferroptosis by targeting FZD7.
Zhang D; Qu B; Hu B; Cao K; Shen H
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Nov; 47(11):1512-1521. PubMed ID: 36481629
[TBL] [Abstract][Full Text] [Related]
13. Expression levels and clinical values of miR-92b-3p in breast cancer.
Du Y; Miao Z; Wang K; Lv Y; Qiu L; Guo L
World J Surg Oncol; 2021 Aug; 19(1):239. PubMed ID: 34380511
[TBL] [Abstract][Full Text] [Related]
14. Identification of serum miR-1915-3p and miR-455-3p as biomarkers for breast cancer.
Guo J; Liu C; Wang W; Liu Y; He H; Chen C; Xiang R; Luo Y
PLoS One; 2018; 13(7):e0200716. PubMed ID: 30048472
[TBL] [Abstract][Full Text] [Related]
15. Analysis of miRNA-221 Expression Level in Tumors and Marginal Biopsies from Patients with Breast Cancer (Cross-Sectional Observational Study).
Abak A; Amini S; Estiar MA; Montazeri V; Sakhinia E; Abhari A
Clin Lab; 2018 Jan; 64(1):169-175. PubMed ID: 29479893
[TBL] [Abstract][Full Text] [Related]
16. miR-214 activates TP53 but suppresses the expression of RELA, CTNNB1, and STAT3 in human cervical and colorectal cancer cells.
Chandrasekaran KS; Sathyanarayanan A; Karunagaran D
Cell Biochem Funct; 2017 Oct; 35(7):464-471. PubMed ID: 29023799
[TBL] [Abstract][Full Text] [Related]
17. miR-629-3p may serve as a novel biomarker and potential therapeutic target for lung metastases of triple-negative breast cancer.
Wang J; Song C; Tang H; Zhang C; Tang J; Li X; Chen B; Xie X
Breast Cancer Res; 2017 Jun; 19(1):72. PubMed ID: 28629464
[TBL] [Abstract][Full Text] [Related]
18. miR-410-3p suppresses breast cancer progression by targeting Snail.
Zhang YF; Yu Y; Song WZ; Zhang RM; Jin S; Bai JW; Kang HB; Wang X; Cao XC
Oncol Rep; 2016 Jul; 36(1):480-6. PubMed ID: 27221455
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-214 suppresses growth, migration and invasion through a novel target, high mobility group AT-hook 1, in human cervical and colorectal cancer cells.
Chandrasekaran KS; Sathyanarayanan A; Karunagaran D
Br J Cancer; 2016 Sep; 115(6):741-51. PubMed ID: 27537384
[TBL] [Abstract][Full Text] [Related]
20. High mobility group A1 (HMGA1) protein and gene expression correlate with ER-negativity and poor outcomes in breast cancer.
Gorbounov M; Carleton NM; Asch-Kendrick RJ; Xian L; Rooper L; Chia L; Cimino-Mathews A; Cope L; Meeker A; Stearns V; Veltri RW; Bae YK; Resar LMS
Breast Cancer Res Treat; 2020 Jan; 179(1):25-35. PubMed ID: 31531802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
